TLS®修身咖啡

*此產品沒有根據《藥劑業及毒藥條例》或《中醫藥條例》註冊。為此產品作出的任何聲明亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用。

不含麩質 - 本產品不含可檢測出之麩質*

不含可檢測出之基改成份(GMO) - 本產品不含可檢測出之基因改造生物成份

純素 - 本產品不含動物相關成份

品質標準 - 良好生產規範(GMP)運作與標準化成份

已檢測：重金屬丶微生物污染物丶過敏原丶效力丶純度及特性

*美國食品藥品監督管理局（FDA）將含有少於20PPM麩質的製成產品列為不含麩質

• Bray G and York D. Clinical review 90: Leptin and clinical medicine: a new piece in the puzzle of obesity. Journal of Clinical Endocrinology and Metabolism. 82(9):2771-6, 1997.
• Cohen P, et al. Selective deletion of leptin receptor in neurons leads to obesity. Journal of Clinical Investigation. 108(8):1113-21, 2001. 
• Friedman JM. The function of leptin in nutrition, weight, and physiology. Nutrition Reviews. 60(10 Pt 2):S1-14; discussion S68-84, 85-7, 2002. Review.
• Gil-Campos M, et al. Adiponectin, the missing link in insulin resistance and obesity. Clinical Nutrition. 23(5):963-74, 2004. Review.
• Hasani-Ranjbar S1, Jouyandeh Z, Abdollahi M. A systematic review of anti-obesity medicinal plants - an update. J Diabetes Metab Disord. 19;12(1):28, 2013. 
• Ngondi J et al. Effect of Irvingia gabonensis kernel oil on blood and liver lipids on lean and overweight rats. Journal of Food Technology. 3:592-4, 2005.  Ngondi J et al. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids in Health and Disease. 8:1-7, 2009. 
• Ngondi J et al. The effect of Irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon. Lipids in Health and Disease. 4:12, 2005. 
• Oben J et al. Inhibition of adipogenesis by Irvingia gabonensis seed extract (IGOB131) as mediated via down regulation of the PPAR gamma and leptin genes, and up-regulation of the adiponectin gene. Lipids in Health and Disease. 7(1):44, 2008. 
• Oben J et al. Irvingia gabonensis on body weight and bloods lipids in normolipidemic guinea pigs. Journal of Food Technology. 3: 472-474, 2005. 
• Qi Y et al. Adiponectin acts in the brain to decrease body weight. Nature Medicine. 10(5):524-9, 2004. 
• Sinha M. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. Journal of Clinical Investigation. 98(6):1277-82, 1996. 
• Swierczynski J et al. Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans. Molecular and Cellular Biochemistry. 254(1-2):55-9, 2003. 
• Wang M et al. Fat storage in adipocytes requires inactivation of leptin’s paracrine activity: implications for treatment of human obesity. Proceedings National Academy of Sciences USA. 102(50):18011-6, 2005. 
• Zeman M et al. Leptin, adiponectin, leptin to adiponectin ratio and insulin resistance in depressive women. Neuro Endocrinology Letters. 30(3):387-95, 2009.